| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:07:50 -0700 |
| HMDB ID |
HMDB00060 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Acetoacetic acid |
| Description |
It is a weak organic acid and can be produced in the human liver under certain conditions of poor metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis), it is then partially converted to acetone by decarboxylation and excreted either in urine or through respiration. Persistent mild hyperketonemia is a common finding in newborns. These compounds serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing rats. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first 2 wk of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies are utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life. (PMID 3884391 ) The acid is also present in the metabolism of those undergoing starvation or prolonged physical exertion as part of gluconeogenesis. When ketone bodies are measured by way of urine concentration, acetoacetic acid, along with beta-hydroxybutyric acid or acetone, is what is detected. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 3-Ketobutyrate
- 3-Ketobutyric acid
- 3-Oxo-butanoate
- 3-Oxo-butanoic acid
- 3-Oxobutyrate
- 3-Oxobutyric acid
- Acetoacetate
- Diacetate
- Diacetic acid
|
| Chemical Formula |
C4H6O3 |
| Average Molecular Weight |
102.0886 |
| Monoisotopic Molecular Weight |
102.031694058 |
| IUPAC Name |
3-oxobutanoic acid |
| Traditional IUPAC Name |
acetoacetic acid |
| CAS Registry Number |
541-50-4 |
| SMILES |
CC(=O)CC(O)=O |
| InChI Identifier |
InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7) |
| InChI Key |
WDJHALXBUFZDSR-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Organic Acids and Derivatives |
| Class |
Keto-Acids and Derivatives |
| Sub Class |
Beta Keto-Acids and Derivatives |
| Other Descriptors |
- 3-oxo monocarboxylic acid(ChEBI)
- Aliphatic Acyclic Compounds
- Organic Compounds
- Oxo fatty acids(KEGG)
- Oxo fatty acids(Lipidmaps)
- Straight Chain Fatty Acids
- short-chain fatty acid(ChEBI)
- straight-chain saturated fatty acid(ChEBI)
|
| Substituents |
- Carboxylic Acid
- Ketone
- Short Chain Keto Acid
|
| Direct Parent |
Beta Keto-Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Butanoate metabolism
- Component of Tyrosine metabolism
|
| Application |
Not Available |
| Cellular locations |
- Cytoplasm
- Extracellular
- Mitochondria
- Peroxisome
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
36.5 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
1000 mg/mL at 20 °C |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Mitochondria
- Peroxisome
|
| Biofluid Locations |
- Blood
- Cellular Cytoplasm
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
- Fibroblasts
- Lymphocyte
- Neuron
- Liver
- Spleen
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
21.0 (0.0-86.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
40.6 +/- 36.5 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cellular Cytoplasm |
Detected and Quantified |
|
1700 (1500-1900) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
26.2 +/- 12.3 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
12.0 +/- 14.0 uM |
Not Specified |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
6.0 +/- 6.0 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.15 (0.01-0.58) umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.20 (0.020-0.82) umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
11.1 (2.2-24.9) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
33.0(0.00-67.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
27.3 +/- 14.4 uM |
Adult (>18 years old) |
Not Specified |
Heart Transplant |
Not Available |
| Blood |
Detected and Quantified |
|
3030.0 +/- 20.0 uM |
Adult (>18 years old) |
Both |
Diabetes |
With ketoacidosis
|
| Cellular Cytoplasm |
Detected and Quantified |
|
1000 (800-1200) uM |
Adult (>18 years old) |
Both |
Anoxia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
248 +/- 179 uM |
Children (1-13 year old) |
Not Specified |
Glucose transporter type 1 deficiency syndrome |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
322.0 (240.0-404.0) uM |
Adult (>18 years old) |
Both |
Meningitis |
Bacterial
|
| Urine |
Detected and Quantified |
|
237.0 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Diabetes |
Not Available |
| Urine |
Detected and Quantified |
|
1.00 (0.00-2.00) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Ketosis |
Not Available |
| Urine |
Detected and Quantified |
|
10025.00 (50.00-20000.00) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Ketosis |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Glucose transporter type 1 deficiency syndrome |
- Klepper J, Diefenbach S, Kohlschutter A, Voit T: Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):321-7.
Pubmed: 14769490
|
| Anoxia |
- Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.
Pubmed: 8579834
|
| Diabetes mellitus type 2 |
- Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.
Pubmed: 15982426
- Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.
Pubmed: 6321058
|
| Meningitis |
- Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.
Pubmed: 15627241
|
| Ketosis |
- http://www.metagene.de/program/d.prg?mp=KETOSIS,%20UNSPECIFIC%20[DD]
|
|
| Associated OMIM IDs |
- 125853
(Diabetes mellitus type 2)
- 606777
(Glucose transporter type 1 deficiency syndrome)
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021801 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
94  |
| KEGG Compound ID |
C00164  |
| BioCyc ID |
3-KETOBUTYRATE  |
| BiGG ID |
1485291  |
| Wikipedia Link |
Acetoacetic acid  |
| NuGOwiki Link |
HMDB00060  |
| Metagene Link |
HMDB00060  |
| METLIN ID |
276  |
| PubChem Compound |
96  |
| PDB ID |
AAE  |
| ChEBI ID |
15344  |
| References |
| Synthesis Reference |
Lopez-Soriano, F. J.; Argiles, J. M. A simple method for the preparation of acetoacetate. Analytical Letters (1985), 18(B5), 589-92. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Heller MJ, Adams PW, Orosz CG: Evaluation of an automated method of percent reactive antibody determination. Hum Immunol. 1992 Nov;35(3):179-87.
Pubmed: 1293081
- Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.
Pubmed: 8579834
- Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.
Pubmed: 15627241
- Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.
Pubmed: 15982426
- Oligny LL, Lough J: Hepatic sinusoidal ectasia. Hum Pathol. 1992 Aug;23(8):953-6.
Pubmed: 1644440
- Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH: Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J. 1984 Jan 15;217(2):365-75.
Pubmed: 6696735
- Galey JB, Destree O, Dumats J, Genard S, Tachon P: Protection against oxidative damage by iron chelators: effect of lipophilic analogues and prodrugs of N,N'-bis(3,4,5-trimethoxybenzyl)ethylenediamine- N,N'-diacetic acid (OR10141). J Med Chem. 2000 Apr 6;43(7):1418-21.
Pubmed: 10753479
- Saibara T, Onishi S, Sone J, Yamamoto N, Shimahara Y, Mori K, Ozawa K, Yamamoto Y: Arterial ketone body ratio as a possible indicator for liver transplantation in fulminant hepatic failure. Transplantation. 1991 Apr;51(4):782-6.
Pubmed: 2014530
- Mahowald ML, Handwerger BS, Capertone EM Jr, Douglas SD: A comparative study of procedures for sheep erythrocyte-human-T-lymphocyte rosette formation. J Immunol Methods. 1977;15(3):239-45.
Pubmed: 404361
- Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.
Pubmed: 8412012
- Sato T, Oouchi M, Nagakubo H, Chiba T, Ogawa S, Sato C, Sugimura K, Fukuda M: Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia. Tohoku J Exp Med. 1998 May;185(1):25-9.
Pubmed: 9710942
- Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC: 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995 Mar 1;67(5):793-811.
Pubmed: 7762816
- Krejsa CM, Schieven GL: Detection of oxidative stress in lymphocytes using dichlorodihydrofluorescein diacetate. Methods Mol Biol. 2000;99:35-47.
Pubmed: 10909075
- Fritzsche I, Buhrdel P, Melcher R, Bohme HJ: Stability of ketone bodies in serum in dependence on storage time and storage temperature. Clin Lab. 2001;47(7-8):399-403.
Pubmed: 11499803
- Polsky-Fisher SL, Cao H, Lu P, Gibson CR: Effect of cytochromes P450 chemical inhibitors and monoclonal antibodies on human liver microsomal esterase activity. Drug Metab Dispos. 2006 Aug;34(8):1361-6. Epub 2006 May 23.
Pubmed: 16720683
- Fulop M, Murthy V, Michilli A, Nalamati J, Qian Q, Saitowitz A: Serum beta-hydroxybutyrate measurement in patients with uncontrolled diabetes mellitus. Arch Intern Med. 1999 Feb 22;159(4):381-4.
Pubmed: 10030312
- Tanaka Y, Ohdan H, Onoe T, Mitsuta H, Tashiro H, Itamoto T, Asahara T: Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation. 2005 May 15;79(9):1262-7.
Pubmed: 15880082
- Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.
Pubmed: 6321058
- de Araujo Burgos MG, Bion FM, Campos F: [Lactation and alcohol: clinical and nutritional effects] Arch Latinoam Nutr. 2004 Mar;54(1):25-35.
Pubmed: 15332353
- Walker V, Mills GA, Mellor JM, Langley GJ, Farrant RD: A novel pyrroline-5-carboxylic acid and acetoacetic acid adduct in hyperprolinaemia type II. Clin Chim Acta. 2003 May;331(1-2):7-17.
Pubmed: 12691858
|